Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers

被引:329
作者
Wolfert, MA
Schacht, EH
Toncheva, V
Ulbrich, K
Nazarova, O
Seymour, LW
机构
[1] UNIV BIRMINGHAM,CRC,INST CANC STUDIES,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
[2] STATE UNIV GHENT,BIOMAT & POLYMER RES GRP,B-9000 GHENT,BELGIUM
[3] ACAD SCI CZECH REPUBL,INST MACROMOL CHEM,PRAGUE 6,CZECH REPUBLIC
关键词
D O I
10.1089/hum.1996.7.17-2123
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cationic polymers can self-assemble with DNA to form polyelectrolyte complexes capable of gene delivery, although biocompatibility of the complexes is generally limited. Here we have used A-B type cationic-hydrophilic block co-polymers to introduce a protective surface hydrophilic shielding following oriented self-assembly with DNA. Block co-polymers of poly(ethylene glycol)-poly-L-lysine (pEG-pLL) and poly-N-(2-hydroxypropyl)methacrylamide-poly(trimethylammonioethyl methacrylate chloride) (pHPMA-pTMAEM) both show spontaneous formation of complexes with DNA. Surface charge measured by zeta potential is decreased compared with equivalent polycation-DNA complexes in each case. Atomic force microscopy shows that pHPMA-pTMAEM/DNA complexes are discrete spheres similar to those formed between DNA and simple polycations, whereas pEG-pLL/DNA complexes adopt an extended structure. Biological properties depend on the charge ratio of formation. At optimal charge ratio, pEG-pLL/DNA complexes show efficient transfection of 293 cells in vitro, while pHPMA-pTMAEM/DNA complexes are more inert, Both block co-polymer-DNA complexes show only limited cytotoxicity. Careful selection of block co-polymer structure can influence the physicochemical and biological properties of the complexes and should permit design of materials for specific applications, including targeted delivery of genes in vivo.
引用
收藏
页码:2123 / 2133
页数:11
相关论文
共 19 条
[1]   LONG-CIRCULATING (STERICALLY STABILIZED) LIPOSOMES FOR TARGETED DRUG-DELIVERY [J].
ALLEN, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :215-220
[2]   AEROSOL AND INTRAVENOUS TRANSFECTION OF HUMAN ALPHA-1-ANTITRYPSIN GENE TO LUNGS OF RABBITS [J].
CANONICO, AE ;
CONARY, JT ;
MEYRICK, BO ;
BRIGHAM, KL .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (01) :24-29
[3]   LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS [J].
CAPLEN, NJ ;
ALTON, EWFW ;
MIDDLETON, PG ;
DORIN, JR ;
STEVENSON, BJ ;
GAO, X ;
DURHAM, SR ;
JEFFERY, PK ;
HODSON, ME ;
COUTELLE, C ;
HUANG, L ;
PORTEOUS, DJ ;
WILLIAMSON, R ;
GEDDES, DM .
NATURE MEDICINE, 1995, 1 (01) :39-46
[4]   ENHANCED RESISTANCE TO NUCLEASE DEGRADATION OF NUCLEIC-ACIDS COMPLEXED TO ASIALOGLYCOPROTEIN-POLYLYSINE CARRIERS [J].
CHIOU, HC ;
TANGCO, MV ;
LEVINE, SM ;
ROBERTSON, D ;
KORMIS, K ;
WU, CH ;
WU, GY .
NUCLEIC ACIDS RESEARCH, 1994, 22 (24) :5439-5446
[5]   Human gene therapy - An immature genie, but certainly out of the bottle [J].
Friedmann, T .
NATURE MEDICINE, 1996, 2 (02) :144-147
[6]   PROCEDURE FOR FACILE SYNTHESIS OF AMINO-ACID N-CARBOXYANHYDRIDES [J].
FULLER, WD ;
VERLANDER, MS ;
GOODMAN, M .
BIOPOLYMERS, 1976, 15 (09) :1869-1871
[7]   MODE OF FORMATION AND STRUCTURAL FEATURES OF DNA CATIONIC LIPOSOME COMPLEXES USED FOR TRANSFECTION [J].
GERSHON, H ;
GHIRLANDO, R ;
GUTTMAN, SB ;
MINSKY, A .
BIOCHEMISTRY, 1993, 32 (28) :7143-7151
[8]   DNA COMPLEXES WITH POLYCATIONS FOR THE DELIVERY OF GENETIC MATERIAL INTO CELLS [J].
KABANOV, AV ;
KABANOV, VA .
BIOCONJUGATE CHEMISTRY, 1995, 6 (01) :7-20
[9]   CYCLIC AMPHIPATHIC PEPTIDE DNA COMPLEXES MEDIATE HIGH-EFFICIENCY TRANSFECTION OF ADHERENT MAMMALIAN-CELLS [J].
LEGENDRE, JY ;
SZOKA, FC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :893-897
[10]   CANCER GENE-THERAPY USING PLASMID DNA - PHARMACOKINETIC STUDY OF DNA FOLLOWING INJECTION IN MICE [J].
LEW, D ;
PARKER, SE ;
LATIMER, T ;
ABAI, AM ;
KUWAHARARUNDELL, A ;
DOH, SG ;
YANG, ZY ;
LAFACE, D ;
GROMKOWSKI, SH ;
NABEL, GJ ;
MANTHORPE, M ;
NORMAN, J .
HUMAN GENE THERAPY, 1995, 6 (05) :553-564